$4.49
-0.25-5.27%
Last update: Nov 9, 7:08 PM
Tonix Pharmaceuticals Holding Corp
TNXPNASDAQ
Tonix Pharmaceuticals (TNXP) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-2.29 | $-2.64 | $-2.51 | $-3.03 |
| Actual | $-2.89 | $-2.44 | $-2.93 | $-3.98 |
| Surprise | -26.2% | +7.58% | -16.7% | -31.4% |
| Revenue | ||||
| Estimate | $16.3M | $7.8M | $7.4M | $2.9M |
| Actual | $17.2M | $13.5M | $6.9M | $5.4M |
| Surprise | +5.82% | +72.9% | -7.30% | +83.8% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-2.27 | $-1.82 | $-1.67 | $-1.57 |
| Revenue | ||||
| Consensus | $19.2M | — | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | Nov 9, 2026 | $-2.89 | $-2.29 | -26.2 % |
| Q2 | Aug 10, 2026 | $-2.44 | $-2.64 | 7.58 % |
| Q1 | May 11, 2026 | $-2.93 | $-2.51 | -16.7 % |
| Q4 | Mar 12, 2026 | $-3.98 | $-3.03 | -31.4 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | Nov 9, 2026 | $17.20M | $16.25M | 5.82 % |
| Q2 | Aug 10, 2026 | $13.54M | $7.83M | 72.9 % |
| Q1 | May 11, 2026 | $6.88M | $7.42M | -7.30 % |
| Q4 | Mar 12, 2026 | $5.39M | $2.93M | 83.8 % |
